FDA Issues Final Order - AVA Safe and Effective, Protects Individuals at High Risk for Anthrax Disease
DoD Resumes Mandatory Anthrax Vaccinations for Select Groups
- POLICIES
- Approval of Anthrax Vaccine Immunization Program Implementation Plan
08 Feb 07
- Implementation of the Anthrax Vaccine Immunization Program (AVIP)
06 Dec 06
Implementation of the AVIP under this memorandum will follow the Assistant Secretary of Defense for Health Affairs approval of Military Service implementation plans. Implementation plans should be submitted within 45 days.
- Anthrax Vaccine Immunization Program
12 Oct 06
- Continuation of the Anthrax Vaccine Immunization Program (AVIP)
22 Dec 05
On 15 Dec 05, the FDA issued a Final Rule & Order on the license status of anthrax vaccine adsorbed (AVA). After reviewing extensive scientific evidence and carefully considering comments from the public, the FDA again determined that AVA is licensed for the prevention of anthrax, regardless of the route of exposure.
In response to the FDA's action, policy options for AVIP are now under review. Unless otherwise directed by the Secretary or Deputy Secretary of Defense, the services are directed to continue implementation of the AVIP as authorized in April 2005. This interim approach will protect the same personnel, and include an option to refuse and weekly reporting requirements.
- SERVICE MESSAGES
- FDA Final Order
|
